BCLI

BRAINSTORM CELL THERAPUTC—+0.00 (—)

Prev Close—·MCap$7.8M·P/E—·Vol—·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$0.00

◆

Net Activity

Net Buyer

$0.00

●

Active Insiders

last 12 mo

BCLI Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value
Sep 30, 2024	Lebovits Chaim	President & CEO	Buy	23,836	$0.47	$11.3K
Jul 19, 2024	Dagher Ibrahim B.	Chief Medical Officer	Sell	63,000	$0.35	$22.1K
Sep 1, 2023	Lindborg Stacy	Co-Chief Executive Officer	Buy	11,500	$1.77	$20.4K

BCLI Insider Buying Activity

The following table shows recent insider purchases of BRAINSTORM CELL THERAPUTC (BCLI) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Sep 30, 2024	Lebovits Chaim	President & CEO	Buy	23,836	$0.47	$11.3K	0
Sep 1, 2023	Lindborg Stacy	Co-Chief Executive Officer	Buy	11,500	$1.77	$20.4K	0

BCLI Insider Selling Activity

The following table shows recent insider sales of BRAINSTORM CELL THERAPUTC (BCLI) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 19, 2024	Dagher Ibrahim B.	Chief Medical Officer	Sell	63,000	$0.35	$22.1K	0

BCLI Insiders

Lebovits Chaim

President & CEO

Bought $11.3K

1 tradesLast: Sep 30, 2024

Dagher Ibrahim B.

Chief Medical Officer

Sold $22.1K

1 tradesLast: Jul 19, 2024

Lindborg Stacy

Co-Chief Executive Officer

Bought $20.4K

1 tradesLast: Sep 1, 2023

Similar Stocks to BCLI

AGNCZ

AGNC Investment Corp. 8.75% Series H Fixed-Rate Cumulative Redeemable Preferred Stock

$25.27-0.10%

$28.00B

AGNCP

AGNC Investment Corp. Depositary Shares Each Representing a 1/1,000th Interest in a Share of 6.125% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock

$25.41-0.24%

$9.83B

USO

United States Oil Fund, LP

$153.72-1.02%

$9.58B

KYN

Kayne Anderson Energy Infrastructure Fund, Inc.

$14.45+0.10%

$2.33B

CLM

Cornerstone Strategic Investment Fund, Inc.